Merck vaccine trial delayed

Merck Vaccine Trial Delayed Amid Concern About Jury
Merck & Co.’s first trial over the safety of its blockbuster Gardasil cancer vaccine was cut short and rescheduled amid concerns that jurors might be influenced by controversy this month around Robert F.
Merck vaccine delayed mid-trial
Merck & Co.'s first trial over the safety of its blockbuster cancer vaccine Gardasil was postponed mid-trial due to concerns that jurors might be influenced by media coverage surrounding the confirmation of Robert F. Kennedy Jr. as HHS Secretary, Bloomberg reported Feb. 18.
Merck Halts HPV Vaccine Trial Amid Controversy
Merck and a plaintiff agreed to pause a case regarding alleged injuries from Merck's HPV vaccine, Gardasil. The case is linked with U.S. Department of Health and Human Services Secretary Robert F. Kennedy Jr.
Merck vaccine trial delayed as RFK Jr. link creates jury concern
A lawyer for the plaintiff in the case said Merck agreed to halting the trial because his team feared that extensive publicity around Kennedy’s Senate confirmation hearings may taint the jury.
Exclusive: Merck vaccine case linked to HHS Secretary Kennedy delayed mid-trial
Merck and a woman suing the drugmaker agreed to halt a trial over alleged injuries from the drugmaker's human papillomavirus vaccine in a case with ties to U.S. Department of Health and Human Services Secretary Robert F.
Pharmalittle: We’re reading about Trump tariffs on drugs, a delayed Merck vaccine court trial, and more
President Trump told reporters that tariffs on pharmaceuticals would start at "25% or higher," but did not say when they would start
Merck Gardasil trial adjourned after RFK Jr. becomes HHS secretary - report
Merck (NYSE:MRK) and a plaintiff who is suing the drugmaker over allegations that the Gardasil HPV vaccine she received as a teen caused her heart issues and nerve pain have agreed to adjourn the trial.
FiercePharma2d
Merck, plaintiff agree to hit the brakes on Gardasil trial in California
Lawsuits surrounding Merck's HPV vaccine Gardasil have been piling up for years now, but they've garnered increased public ...
Merck shares plunge as company pauses Gardasil vaccine shipments in China, hurting 2025 outlook
Merck's full-year 2025 revenue guidance fell short of what some analysts were expecting, at a range of $64.1 billion to $65.6 billion.
Is Merck Stock a Buy?
Merck shares have been under pressure amid disappointing sales trends for its Gardasil HPV vaccine. The company's broader ...
BioSpace3d
RFK Jr.-Linked Lawsuit Against Merck Suspended After Confirmation: Reuters
Recently appointed HHS Secretary Robert F. Kennedy Jr. in 2018 helped bring several cases against vaccine maker Merck, ...
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MRK
Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Merck & Co., Inc. (NYSE: MRK) between February 3, 2022 and February 3, 2025, both dates inclusive (the "Class ...
devdiscourse4d
Merck's Gardasil Controversy: Legal Battle Revived in Los Angeles
Merck and a plaintiff have paused a trial over alleged injuries from the HPV vaccine Gardasil, with ties to HHS Secretary ...
STAT18d
Merck’s earnings miss focused attention on Gardasil. The real issue is Keytruda
Merck on Tuesday missed earnings estimates, lowered its guidance for this year’s earnings, and withdrew a target for sales of its HPV vaccine, Gardasil, to reach $11 billion by 2030. The result ...
Merck’s struggles with HPV vaccine send stock to worst selloff in almost 17 years
Merck’s stock tumbled 6% early Tuesday, after the drug company’s softer-than-expected guidance for the current year offset better-than-expected fourth-quarter earnings.
MRK INVESTOR DEADLINE: Merck & Co., Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
February 20, 2025) - The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Merck & Co., Inc. (NYSE: MRK) securities between February 3, 2022 and February 3, 2025, ...